Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartphone Check-Ins could boost TB treatment success

NCT ID NCT07069387

Disease control Sponsor: University of Malaya Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests a digital package called CARE-TB to help people with tuberculosis take their medication as prescribed. The package includes video observation of pill-taking, digital reminders, telecounselling, and educational materials. Researchers will compare this approach to standard in-person observation in about 80 adults with pulmonary TB in Malaysia. The goal is to see if the digital method improves adherence and treatment completion.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
CARE-TB digital adherence package (video-observed therapy, digital reminders, telecounselling, e-learning)
What this could lead to
If effective, this approach could improve TB treatment completion rates and reduce disease spread, relapse, and drug resistance.
What could go wrong
This is a small, early-stage study in one region, so results may not apply broadly. Digital adherence relies on patient access to technology and willingness to engage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

81 people

The number who actually took part.

Started

Apr 2025

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Microbiologically confirmed pulmonary TB (smear- or culture-positive PTB) 2. 18 years old or older 3. Able to give consent and physically able to participate in the study 4. Own a video-recording device with internet connectivity 5. Within the first 3 weeks of intensive phase TB treatment Exclusion Criteria: 1. Complicated TB disease including TB meningitis, TB bone/joint, and disseminated TB with planned treatment duration of 9 to 12 months. 2. Confirmed or suspected drug-resistant (DR)-TB 3. Documented cognitive, motor, or visual disability that will hinder video device use and lack assistance of a caretaker 4. Receiving injectable anti-TB drugs 5. Incarceration or other involuntary detention

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pulmonary tuberculosis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

latent tuberculosis infection pulmonary tuberculosis tuberculosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Tuberculosis (TB)

Contacts and locations

Locations

  • Sungai Buloh Hospital

    Sungai Buloh, Selangor, 47000, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.